v3.22.2.2
Nature of Operations (Details Narrative) - USD ($)
6 Months Ended
Apr. 06, 2021
Jan. 05, 2021
Apr. 17, 2020
Mar. 05, 2020
Jun. 25, 2019
Sep. 30, 2022
Mar. 31, 2022
Mar. 04, 2020
Entity incorporation, date of incorporation           Mar. 02, 2016    
Entity incorporation, state or country code           NV    
Common stock, shares authorized       100,000,000   1,500,000,000 1,500,000,000 75,000,000
Preferred stock authorized           150,000,000 150,000,000  
Stockholders equity description       12.6374:1        
Common stock, par value           $ 0.001 $ 0.001  
Minimum [Member]                
Common stock, shares authorized 100,000,000              
Preferred stock authorized 10,000,000              
Maximum [Member]                
Common stock, shares authorized 1,500,000,000              
Preferred stock authorized 150,000,000              
Exchange Agreement [Member] | Mr. Amer Samad [Member] | Bed Therapies Inc [Member]                
Stockholders equity description the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 to 1,500,000,000, (ii) increase the Company’s authorized shares of “blank check” preferred stock from 10,000,000 to 150,000,000, and (iii) effect a 1:15 forward stock split of the common stock.              
Blank Check [Member]                
Preferred stock authorized       10,000,000        
Maksim Charniak [Member]                
Equity method investment description           On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 shares (pre- stock split) of the Company’s common stock, sold all his shares of common stock of the Company to Amer Samad, resulting in a change of control of the Company. As part of that transaction, Mr. Charniak resigned from all of his officer and director positions, and Mr. Samad was appointed as the Chief Executive Officer, President, Chief Financial Officer and Secretary of the Company, and was appointed to the Board of Directors of the Company. Mr. Samad also purchased 1,167,937 shares (pre-stock split) of the Company’s common stock in a series of private transactions, resulting in Mr. Samad owning 4,167,937 shares (pre-stock split) of the Company’s common stock, or approximately 95.6% of the issued and outstanding common stock of the Company.    
Mr. Amer Samad [Member]                
Stock issued during period shares stock splits         3,000,000      
Ownership percentage         95.60%      
Bed Therapies Inc [Member] | Exchange Agreement [Member]                
Stock issued during period shares stock splits   1,269,665            
Ownership percentage     100.00%          
Stockholders equity description Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888              
Common stock, par value     $ 0.001          
Debt conversion, converted instrument, amount     $ 539,000          
Bed Therapies Inc [Member] | Exchange Agreement [Member] | Mr. Amer Samad [Member]                
Cancellation of stock split     52,656,888